Skip to main content
Log in

Parkinsonism with prominent neuropsychiatric symptoms without pyramidal involvement in a patient with FBXO7 variants

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

The data supporting this study's findings are not openly available and are available from the corresponding author upon reasonable request.

References

  1. Paisán-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, Houlden H (2010) Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25:1791–1800

    Article  PubMed  PubMed Central  Google Scholar 

  2. Shojaee S, Sina F, Banihosseini SS, Kazemi MH, Kalhor R, Shahidi GA, Fakhrai-Rad H, Ronaghi M, Elahi E (2008) Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet 82:1375–1384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, Correia Guedes L, Szczerbinska A, Zhao T, Dubbel-Hulsman LO, Wouters CH, de Graaff E, Oyen WJ, Simons EJ, Breedveld GJ, Oostra BA, Horstink MW, Bonifati V (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72:240–245

    Article  PubMed  Google Scholar 

  4. Morales-Briceño H, Mohammad SS, Post B, Fois AF, Dale RC, Tchan M, Fung VSC (2020) Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence. Brain 143:751–770

    Article  PubMed  Google Scholar 

  5. Conedera S, Apaydin H, Li Y, Yoshino H, Ikeda A, Matsushima T, Funayama M, Nishioka K, Hattori N (2016) FBXO7 mutations in Parkinson’s disease and multiple system atrophy. Neurobiol Aging 40:192.e1-192.e5

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No specific funding was received for this work.

Author information

Authors and Affiliations

Authors

Contributions

1. Research project: (A) conception, (B) organisation, (C) execution.

2. Statistical analysis: (A) design, (B) execution, (C) review and critique.

3. Manuscript preparation: (A) writing of the first draft, (B) review and critique.

SM: 1B, 1C, 3A, 3B.

SM: 1B, 1C.

JS: 1B, 1C.

SM: 1A, 1B, 1C, 3A, 3B.

VL: 1C, 3B.

Corresponding author

Correspondence to Sahil Mehta.

Ethics declarations

Ethical approval

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that the approval of an institutional review board was not required for this work. However, informed consent was obtained and is being submitted with the manuscript.

Conflict of interest

The authors declare that there are no conflicts of interest relevant to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (MOV 18739 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahajan, S., Mehta, S., Singh, J. et al. Parkinsonism with prominent neuropsychiatric symptoms without pyramidal involvement in a patient with FBXO7 variants. Neurol Sci 45, 1279–1281 (2024). https://doi.org/10.1007/s10072-023-07132-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-07132-w

Navigation